Ebola Virus Disease in Humans: Pathophysiology and Immunity
- PMID: 28653186
- PMCID: PMC7122202
- DOI: 10.1007/82_2017_11
Ebola Virus Disease in Humans: Pathophysiology and Immunity
Abstract
Viruses of the Ebolavirus genus cause sporadic epidemics of severe and systemic febrile disease that are fueled by human-to-human transmission. Despite the notoriety of ebolaviruses, particularly Ebola virus (EBOV), as prominent viral hemorrhagic fever agents, and the international concern regarding Ebola virus disease (EVD) outbreaks, very little is known about the pathophysiology of EVD in humans and, in particular, about the human immune correlates of survival and immune memory. This lack of basic knowledge about physiological characteristics of EVD is probably attributable to the dearth of clinical and laboratory data gathered from past outbreaks. The unprecedented magnitude of the EVD epidemic that occurred in West Africa from 2013 to 2016 has allowed, for the first time, evaluation of clinical, epidemiological, and immunological parameters in a significant number of patients using state-of-the-art laboratory equipment. This review will summarize the data from the literature regarding human pathophysiologic and immunologic responses to filoviral infection.
Similar articles
-
Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease.Emerg Infect Dis. 2016 Jan;22(1):105-8. doi: 10.3201/eid2201.151410. Emerg Infect Dis. 2016. PMID: 26691346 Free PMC article.
-
Treatment of ebola virus disease.Pharmacotherapy. 2015 Jan;35(1):43-53. doi: 10.1002/phar.1545. Pharmacotherapy. 2015. PMID: 25630412 Review.
-
The Ebola virus glycoprotein and its immune responses across multiple vaccine platforms.Expert Rev Vaccines. 2020 Mar;19(3):267-277. doi: 10.1080/14760584.2020.1738225. Epub 2020 Mar 16. Expert Rev Vaccines. 2020. PMID: 32129120 Review.
-
Development of an Immunochromatography Assay (QuickNavi-Ebola) to Detect Multiple Species of Ebolaviruses.J Infect Dis. 2016 Oct 15;214(suppl 3):S185-S191. doi: 10.1093/infdis/jiw252. Epub 2016 Jul 26. J Infect Dis. 2016. PMID: 27462094 Free PMC article.
-
Delayed recognition of Ebola virus disease is associated with longer and larger outbreaks.Emerg Microbes Infect. 2020 Feb 4;9(1):291-301. doi: 10.1080/22221751.2020.1722036. eCollection 2020. Emerg Microbes Infect. 2020. PMID: 32013784 Free PMC article.
Cited by
-
Characterization of Ebola Virus Mucosal Challenge Routes in Cynomolgus Macaques.J Virol. 2023 May 31;97(5):e0188822. doi: 10.1128/jvi.01888-22. Epub 2023 Mar 28. J Virol. 2023. PMID: 36975793 Free PMC article.
-
Diagnostics of Ebola virus.Front Public Health. 2023 Feb 23;11:1123024. doi: 10.3389/fpubh.2023.1123024. eCollection 2023. Front Public Health. 2023. PMID: 36908455 Free PMC article. Review.
-
Epidemiology of Ebolaviruses from an Etiological Perspective.Pathogens. 2023 Feb 3;12(2):248. doi: 10.3390/pathogens12020248. Pathogens. 2023. PMID: 36839520 Free PMC article. Review.
-
Use of Hu-PBL Mice to Study Pathogenesis of Human-Restricted Viruses.Viruses. 2023 Jan 13;15(1):228. doi: 10.3390/v15010228. Viruses. 2023. PMID: 36680271 Free PMC article. Review.
-
In vivo characterization of the novel ebolavirus Bombali virus suggests a low pathogenic potential for humans.Emerg Microbes Infect. 2023 Dec;12(1):2164216. doi: 10.1080/22221751.2022.2164216. Epub 2023 Jan 18. Emerg Microbes Infect. 2023. PMID: 36580440 Free PMC article.
References
-
- Adjemian J, Farnon EC, Tschioko F, Wamala JF, Byaruhanga E, Bwire GS, Kansiime E, Kagirita A, Ahimbisibwe S, Katunguka F, Jeffs B, Lutwama JJ, Downing R, Tappero JW, Formenty P, Amman B, Manning C, Towner J, Nichol ST, Rollin PE. Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. J Infect Dis. 2011;204(Suppl 3):S796–799. doi: 10.1093/infdis/jir312. - DOI - PMC - PubMed
-
- Agnandji ST, Huttner A, Zinser ME, Njuguna P, Dahlke C, Fernandes JF, Yerly S, Dayer JA, Kraehling V, Kasonta R, Adegnika AA, Altfeld M, Auderset F, Bache EB, Biedenkopf N, Borregaard S, Brosnahan JS, Burrow R, Combescure C, Desmeules J, Eickmann M, Fehling SK, Finckh A, Goncalves AR, Grobusch MP, Hooper J, Jambrecina A, Kabwende AL, Kaya G, Kimani D, Lell B, Lemaitre B, Lohse AW, Massinga-Loembe M, Matthey A, Mordmuller B, Nolting A, Ogwang C, Ramharter M, Schmidt-Chanasit J, Schmiedel S, Silvera P, Stahl FR, Staines HM, Strecker T, Stubbe HC, Tsofa B, Zaki S, Fast P, Moorthy V, Kaiser L, Krishna S, Becker S, Kieny MP, Bejon P, Kremsner PG, Addo MM, Siegrist CA. Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe. N Engl J Med. 2016;374(17):1647–1660. doi: 10.1056/NEJMoa1502924. - DOI - PMC - PubMed
-
- Amman BR, Carroll SA, Reed ZD, Sealy TK, Balinandi S, Swanepoel R, Kemp A, Erickson BR, Comer JA, Campbell S, Cannon DL, Khristova ML, Atimnedi P, Paddock CD, Crockett RJ, Flietstra TD, Warfield KL, Unfer R, Katongole-Mbidde E, Downing R, Tappero JW, Zaki SR, Rollin PE, Ksiazek TG, Nichol ST, Towner JS. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog. 2012;8(10):e1002877. doi: 10.1371/journal.ppat.1002877. - DOI - PMC - PubMed
-
- Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GM, Papagno L, Ogg GS, King A, Lechner F, Spina CA, Little S, Havlir DV, Richman DD, Gruener N, Pape G, Waters A, Easterbrook P, Salio M, Cerundolo V, McMichael AJ, Rowland-Jones SL. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8(4):379–385. doi: 10.1038/nm0402-379. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous